274 related articles for article (PubMed ID: 30244398)
1. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
[TBL] [Abstract][Full Text] [Related]
2. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
3. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
4. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
[TBL] [Abstract][Full Text] [Related]
5. Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Chan M; Fung M; Chin Koon Siw K; Khanna R; de Buck van Overstraeten A; Sabri E; McCurdy JD
Inflamm Bowel Dis; 2023 May; 29(5):763-770. PubMed ID: 35815783
[TBL] [Abstract][Full Text] [Related]
6. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
[TBL] [Abstract][Full Text] [Related]
7. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Melmed GY; Spiegel BM; Bressler B; Cheifetz AS; Devlin SM; Harrell LE; Irving PM; Jones J; Kaplan GG; Kozuch PL; Velayos FS; Baidoo L; Sparrow MP; Siegel CA
Clin Gastroenterol Hepatol; 2010 Aug; 8(8):655-9. PubMed ID: 20451665
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
Osterman MT; Haynes K; Delzell E; Zhang J; Bewtra M; Brensinger CM; Chen L; Xie F; Curtis JR; Lewis JD
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1293-1301.e5; quiz e70, e72. PubMed ID: 25724699
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease.
Singh S; Heien HC; Sangaralingham LR; Schilz SR; Kappelman MD; Shah ND; Loftus EV
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1120-1129.e6. PubMed ID: 27058635
[TBL] [Abstract][Full Text] [Related]
11. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study.
Agrawal M; Ebert AC; Poulsen G; Ungaro RC; Faye AS; Jess T; Colombel JF; Allin KH
Gastroenterology; 2023 Oct; 165(4):976-985.e3. PubMed ID: 37321356
[TBL] [Abstract][Full Text] [Related]
12. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
Tandon P; Rhee GG; Schwartz D; McCurdy JD
Dig Dis Sci; 2019 Nov; 64(11):3066-3077. PubMed ID: 31030304
[TBL] [Abstract][Full Text] [Related]
13. Impact of medical therapy on patients with Crohn's disease requiring surgical resection.
Fu YT; Hong T; Round A; Bressler B
World J Gastroenterol; 2014 Sep; 20(33):11808-14. PubMed ID: 25206286
[TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
Nuti F; Civitelli F; Bloise S; Oliva S; Aloi M; Latorre G; Viola F; Cucchiara S
J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
[TBL] [Abstract][Full Text] [Related]
15. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
[TBL] [Abstract][Full Text] [Related]
16. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease.
Vuyyuru SK; Kante B; Kumar P; Sahu P; Kedia S; Ranjan MK; Sharma R; Panwar R; Makharia G; Ahuja V
Sci Rep; 2021 Jun; 11(1):11704. PubMed ID: 34083575
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy.
Yarur AJ; Jain A; Quintero MA; Czul F; Deshpande AR; Kerman DH; Abreu MT
J Clin Gastroenterol; 2019 Mar; 53(3):210-215. PubMed ID: 29517712
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis.
Targownik LE; Tennakoon A; Leung S; Lix LM; Singh H; Bernstein CN
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1061-1070.e1. PubMed ID: 28238957
[TBL] [Abstract][Full Text] [Related]
19. Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn's Disease.
Shinagawa T; Hata K; Ikeuchi H; Fukushima K; Futami K; Sugita A; Uchino M; Watanabe K; Higashi D; Kimura H; Araki T; Mizushima T; Itabashi M; Ueda T; Koganei K; Oba K; Ishihara S; Suzuki Y
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):898-907.e5. PubMed ID: 31336198
[TBL] [Abstract][Full Text] [Related]
20. A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.
Siegel CA; Horton H; Siegel LS; Thompson KD; Mackenzie T; Stewart SK; Rice PW; Stempak JM; Dezfoli S; Haritunians T; Levy A; Baek M; Milgrom R; Dulai PS; Targan SR; Silverberg MS; Dubinsky MC; McGovern DP
Aliment Pharmacol Ther; 2016 Jan; 43(2):262-71. PubMed ID: 26567467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
